C04931 |
Argatroban; (2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperadinecarboxylic acid |
(P) unclassified |
C06921 |
Clorazepate; Clorazepic acid |
(P) unclassified |
C07051 |
Indinavir |
(P) unclassified |
D00105 |
Estradiol (JAN/USP/INN); Climara (TN); Divigel (TN); Estrace (TN); Estraderm (TN); Estrasorb (TN); Estring (TN); Estrogel (TN); Innofem (TN); Vagifem (TN); Vivelle (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00106 |
Epoprostenol (USAN/INN); Prostaglandin I2; Prostacyclin; Epoprostenol (TN) |
(P) unclassified |
D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18); Prograf (TN); Protopic (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00109 |
Aspirin (JP18/USP); Aspalon (JAN); Acetylsalicylic acid; Easprin (TN); Durlaza (TN) |
(P) unclassified |
D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00181 |
Argatroban (USP); Argatroban hydrate (JP18); Novastan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00184 |
Cyclosporine (USP); Ciclosporin (JP18); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
D00219 |
Acetohexamide (JP18/USP/INN); Dymelor (TN) |
(P) unclassified |
D00225 |
Alprazolam (JP18/USP/INN); Xanax (TN) |
(P) unclassified |
D00246 |
Budesonide (JP18/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D00267 |
Chlordiazepoxide (JP18/USP/INN); Libritabs (TN) |
(P) unclassified |
D00271 |
Chlorpropamide (JP18/USP/INN); Diabinese (TN) |
(P) unclassified |
D00280 |
Clonazepam (JP18/USP/INN); Klonopin (TN) |
(P) unclassified |
D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00297 |
Digitoxin (JAN/USP/INN); Crystodigin (TN) |
(P) Transporter inhibition: ABCB1 |
D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) Transporter inhibition: ABCB1 |
D00302 |
Dipyridamole (JP18/USP/INN); Persantine (TN) |
(P) unclassified |
D00303 |
Disopyramide (JP18/USAN/INN); Rythmodan P (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
D00311 |
Estazolam (JP18/USP/INN); ProSom (TN) |
(P) unclassified |
D00319 |
Felodipine (JP18/USP/INN); Plendil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00329 |
Flurazepam (JAN/INN); Insumin (TN) |
(P) unclassified |
D00335 |
Glipizide (USP/INN); Glucotrol (TN) |
(P) unclassified |
D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00338 |
Halazepam (USAN/INN); Paxipam (TN) |
(P) unclassified |
D00349 |
Isradipine (USP/INN); Dynacirc (TN) |
(P) unclassified |
D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00359 |
Lovastatin (USP/INN); MK-803; ML-530B; Mevacor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00365 |
Lorazepam (JP18/USP/INN); Ativan (TN) |
(P) unclassified |
D00370 |
Temazepam (USP/INN); Restoril (TN) |
(P) unclassified |
D00371 |
Theophylline (JP18); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) unclassified |
D00379 |
Tolazamide (JAN/USP/INN); Tolinase (TN) |
(P) unclassified |
D00380 |
Tolbutamide (JP18/USP/INN); Orinase (TN) |
(P) unclassified |
D00387 |
Triazolam (JP18/USP/INN); Halcion (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
D00424 |
Rifabutin (JAN/USP/INN); Mycobutin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(P) unclassified |
D00429 |
Saquinavir (JAN/USP/INN); Fortovase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00434 |
Simvastatin (JP18/USP/INN); MK-733; Zocor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00437 |
Nifedipine (JP18/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00454 |
Olanzapine (JAN/USP/INN); Zyprexa (TN) |
(P) unclassified |
D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00458 |
Quetiapine fumarate (JP18/USP); Seroquel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00464 |
Oxazepam (JAN/USP/INN); Serax (TN) |
(P) unclassified |
D00470 |
Prazepam (JP18/USAN/INN); Centrax (TN) |
(P) unclassified |
D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) unclassified |
D00528 |
Caffeine (USP); Anhydrous caffeine (JP18); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
D00531 |
Nitrazepam (JP18/USAN/INN); Benzalin (TN); Nitrazepam (TN) |
(P) unclassified |
D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00538 |
Zonisamide (JP18/USP/INN); Excegran (TN) |
(P) unclassified |
D00539 |
Ethosuximide (JP18/USP/INN); Zarontin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00553 |
Prilocaine (USP/INN); Propitocaine (JAN) |
(P) unclassified |
D00560 |
Pimozide (JP18/USP/INN); Orap (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) unclassified |
D00570 |
Colchicine (JP18/USP); Colchicine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00593 |
Glimepiride (JP18/USP/INN); Amaryl (TN) |
(P) unclassified |
D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP18); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00616 |
Diltiazem hydrochloride (JP18/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00617 |
Nicardipine hydrochloride (JP18/USAN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00629 |
Nitrendipine (JP18/USAN/INN); Baypress (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00637 |
Disopyramide phosphate (JAN/USP); Norpace (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00664 |
Cetirizine hydrochloride (JP18/USP); Zyrtec (TN) |
(P) Transporter inhibition: ABCB1 |
D00670 |
Donepezil hydrochloride (JP18/USP); Aricept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00679 |
Ergotamine tartrate (JP18/USP); Ergomar (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP18); Methergine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00690 |
Mometasone furoate (JAN/USP); Asmanex (TN); Elocon (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00693 |
Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) |
(P) unclassified |
D00694 |
Clorazepate dipotassium (JP18/USP); Tranxene (TN) |
(P) unclassified |
D00695 |
Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) |
(P) unclassified |
D00696 |
Midazolam hydrochloride (USAN); Versed (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
D00710 |
Valproate sodium (USAN); Sodium valproate (JP18); Depakene (TN); Selenica (TN) |
(P) unclassified |
D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP18); Ditropan (TN); Gelnique (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00729 |
Loperamide hydrochloride (JAN/USP); Imodium (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00769 |
Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP18); Clopidogrel sulfate tablets (JP18); Clopidogrel hydrogen sulphate; Isocover (TN); Plavix (TN) |
(P) unclassified |
D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18); Parlodel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00804 |
Ivermectin (JAN/USP/INN); Sklice (TN); Soolantra (TN); Stromectol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) unclassified |
D00822 |
Citalopram hydrobromide (USP); Celexa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
D00836 |
Buprenorphine hydrochloride (JP18/USP); Buprenex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00887 |
Atorvastatin calcium anhydorous; Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00896 |
Efavirenz (JAN/USP/INN); Sustiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D00973 |
Cortisone acetate (JP18/USP); Cortone acetate (TN) |
(P) unclassified |
D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D00977 |
Hydrocortisone sodium phosphate (JP18/USP); Hydrocortone phosphate (TN) |
(P) unclassified |
D00981 |
Prednisolone sodium phosphate (JP18/USP); Pediapred (TN) |
(P) unclassified |
D00987 |
Cabergoline (JP18/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01028 |
Ticlopidine hydrochloride (JP18/USP); Ticlid (TN) |
(P) unclassified |
D01029 |
Tirofiban hydrochloride (USAN); Tirofiban hydrochloride hydrate; Aggrastat (TN) |
(P) unclassified |
D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
D01068 |
Vinblastine sulfate (JP18/USP); Exal (TN); Velban (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01115 |
Eplerenone (JP18/USAN/INN); Inspra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01145 |
Azelnidipine (JP18/INN); Calblock (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01148 |
Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01160 |
Saquinavir mesylate (USP); Saquinavir mesilate (JAN); Invirase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D01164 |
Aripiprazole (JAN/USP/INN); Abilify (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01173 |
Cilnidipine (JP18/INN); Atelec (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01176 |
Blonanserin (JAN/INN); AD 5423 |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01204 |
Olmesartan medoxomil (JP18/USP); Benicar (TN); Olmetec (TN) |
(P) Transporter inhibition: ABCB1 |
D01213 |
Tolvaptan (JAN/USAN/INN); Samsca (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D01220 |
Trapidil (JP18/INN); Rocornal (TN) |
(P) unclassified |
D01230 |
Flunitrazepam (JP18/USAN/INN); Rohypnol (TN) |
(P) unclassified |
D01243 |
Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN); Citanest (TN) |
(P) unclassified |
D01245 |
Bromazepam (JP18/USAN/INN); Lectopam (TN) |
(P) unclassified |
D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01254 |
Tofisopam (JP18/INN); Emandaxin (TN) |
(P) unclassified |
D01268 |
Cloxazolam (JP18/INN); Sepazon (TN) |
(P) unclassified |
D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
D01278 |
Oxazolam (JP18/INN); Serenal (TN) |
(P) unclassified |
D01279 |
Flutoprazepam (JP18/INN); Restas (TN) |
(P) unclassified |
D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
D01286 |
Flutazolam (JAN/INN); Coreminal (TN) |
(P) unclassified |
D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01292 |
Medazepam (JP18/INN); Pamnace (TN) |
(P) unclassified |
D01293 |
Ethyl loflazepate (JP18/INN); Meilax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01303 |
Flunarizine hydrochloride (JAN/USAN) |
(P) unclassified |
D01316 |
Mexazolam (JAN/INN); Melex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01328 |
Clotiazepam (JP18/INN); Rize (TN) |
(P) unclassified |
D01337 |
Epoprostenol sodium (JAN/USAN); Flolan (TN); Veletri (TN) |
(P) unclassified |
D01354 |
Fludiazepam (JP18/INN); Erispan (TN) |
(P) unclassified |
D01372 |
Zopiclone (JP18/INN); Amoban (TN); Zopiclone (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01399 |
Fentanyl citrate (JP18/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01408 |
Flurazepam hydrochloride (JP18); Flurazepam monohydrochloride; Dalmate (TN) |
(P) unclassified |
D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01425 |
Lopinavir (JAN/USP/INN) |
(P) unclassified |
D01441 |
Imatinib mesylate (USAN); Imatinib mesilate (JAN); Gleevec (TN); Glivec (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01514 |
Etizolam (JP18/INN); Sedekopan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01551 |
Beraprost sodium (JP18/USAN); Procylin (TN) |
(P) unclassified |
D01553 |
Manidipine hydrochloride (JP18); Manidipine dihydrochloride; Calslot (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01564 |
Rilmazafone hydrochloride hydrate (JP18); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochloride; Rhythmy (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01593 |
Nimetazepam (JAN/INN); Erimin (TN) |
(P) unclassified |
D01599 |
Gliclazide (JP18/INN); Glimicron (TN) |
(P) unclassified |
D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
D01615 |
Dexamethasone palmitate (JAN); Dexamethasone 21-palmitate; Limethason (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D01624 |
Sarpogrelate hydrochloride (JP18); Anplag (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01656 |
Brovincamine fumarate (JAN); Sabromin (TN) |
(P) unclassified |
D01657 |
Lormetazepam (JAN/USAN/INN); Loramet (TN) |
(P) unclassified |
D01663 |
Quinine ethylcarbonate (JP18); Quinine ethylcarbonate (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D01670 |
Nafamostat mesylate (USAN); Nafamostat mesilate (JP18); Ronastat (TN) |
(P) unclassified |
D01672 |
Gabexate mesilate (JP18); Gabexate mesylate; Arodate (TN) |
(P) unclassified |
D01683 |
Ozagrel hydrochloride hydrate (JAN); Ozagrel hydrochloride; Ozagrel (TN) |
(P) unclassified |
D01684 |
Ozagrel sodium (JP18); Ozapen (TN) |
(P) unclassified |
D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01712 |
Theophylline sodium acetate (JAN) |
(P) unclassified |
D01744 |
Brotizolam (JP18/USAN/INN); Lendormin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01745 |
Domperidone (JP18/USAN/INN); Motilium (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01758 |
Haloxazolam (JP18/INN); Somelin (TN) |
(P) unclassified |
D01799 |
Glyclopyramide (JAN/INN); Deamelin-S (TN) |
(P) unclassified |
D01810 |
Nicorandil (JP18/USAN/INN); Sigmart (TN) |
(P) unclassified |
D01844 |
Fondaparinux sodium (JAN/USP/INN); Arixtra (TN) |
(P) unclassified |
D01849 |
Lercanidipine hydrochloride (JAN/USAN); Cardiovasc (TN) |
(P) unclassified |
D01892 |
Icosapent ethyl (USAN); Ethyl icosapentate (JP18); Epadel S (TN); Vascepa (TN) |
(P) unclassified |
D01896 |
Cilostazol (JP18/USP/INN); Pletal (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01908 |
Nilvadipine (JP18/USAN/INN); Nivadil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01915 |
Rosuvastatin calcium (JP18/USP); ZD 4522; Crestor (TN) |
(P) unclassified |
D01933 |
Vatanidipine hydrochloride (JAN); AE 0047; Calbren (TN) |
(P) unclassified |
D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01969 |
Gallopamil hydrochloride (JAN) |
(P) unclassified |
D01973 |
Eletriptan hydrobromide (JAN/USAN); Relpax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
D01981 |
Ximelagatran (JAN/USAN/INN); Exanta (TN) |
(P) unclassified |
D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02045 |
Benidipine hydrochloride (JP18); KW 3049; Coniel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
D02106 |
Arsenic trioxide (JP18/USAN); Trisenox (TN) |
(P) unclassified |
D02112 |
Heparin sodium (JP18/USP/INN); Parnaparin sodium (INN); Liquemin sodium (TN) |
(P) unclassified |
D02134 |
Azithromycin hydrate (JP18); Azithromycin dihydrate; Zithromac (TN); Zmax (TN); Azimycin (TN) |
(P) Transporter inhibition: ABCB1 |
D02165 |
Docetaxel (USP); Docetaxel hydrate (JP18); Docetaxel trihydrate; Taxotere (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02168 |
Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN); Hycamtin (TN); Potactasol (TN) |
(P) Transporter inhibition: ABCB1 |
D02211 |
Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP18); Migranal (TN); Trudhesa (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02261 |
Quinine hydrochloride hydrate (JP18); Quinine hydrochloride dihydrate; Quinine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02262 |
Quinine sulfate (USP); Quinine sulfate hydrate (JP18); Quinine hydrogen sulfate; Coco-quinine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
D02425 |
Carbutamide (INN); Invenol (TN) |
(P) unclassified |
D02426 |
Glycyclamide (INN); Tolcyclamide |
(P) unclassified |
D02427 |
Glibornuride (USAN/INN); Glutril (TN) |
(P) unclassified |
D02428 |
Glisentide (INN); Glypentide; Staticum (TN) |
(P) unclassified |
D02429 |
Glisolamide (INN); Glysolamide; Diabenor (TN) |
(P) unclassified |
D02430 |
Gliquidone (INN); Glurenorm (TN) |
(P) unclassified |
D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(P) unclassified |
D02537 |
Dronedarone (INN) |
(P) unclassified |
D02554 |
Rifaximin (JAN/USAN/INN); Xifaxan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) Transporter inhibition: ABCB1 |
D02600 |
Demoxepam (USAN/INN) |
(P) unclassified |
D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02629 |
Fluspirilene (USAN/INN); Imap (TN) |
(P) unclassified |
D02630 |
Penfluridol (USAN/INN); Semap (TN) |
(P) unclassified |
D02633 |
Lomerizine hydrochloride (JAN); Terranas (TN) |
(P) unclassified |
D02666 |
Iloperidone (USAN/INN); Fanapt (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D02720 |
Beraprost (USAN) |
(P) unclassified |
D02721 |
Iloprost (USAN/INN); Ventavis (TN) |
(P) unclassified |
D02722 |
Limaprost (INN) |
(P) unclassified |
D02731 |
Vardenafil dihydrochoride (USAN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02770 |
Adinazolam (USAN/INN) |
(P) unclassified |
D02771 |
Adinazolam mesylate (USAN) |
(P) unclassified |
D02778 |
Abciximab (USAN/INN); Abciximab (genetical recombination) (JAN); Reopro (TN) |
(P) unclassified |
D02837 |
Alteplase (USP/INN); Alteplase (genetical recombination) (JAN); Activase (TN); Cathflo activase (TN) |
(P) unclassified |
D02860 |
Limaprost alfadex (JP18); Opalmon (TN) |
(P) unclassified |
D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D02938 |
Ancrod (USAN/INN); Viprinex (TN) |
(P) unclassified |
D02947 |
Anistreplase (USAN/INN); Eminase (TN) |
(P) unclassified |
D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D02980 |
Adomiparin sodium (USAN); Ardeparin sodium (USAN/INN); Semuloparin sodium (USAN/INN); Normiflo (TN) |
(P) unclassified |
D03067 |
Belfosdil (USAN/INN) |
(P) unclassified |
D03083 |
Bentazepam (USAN/INN) |
(P) unclassified |
D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
D03136 |
Bivalirudin (USAN/INN) |
(P) unclassified |
D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
D03157 |
Brinolase (USAN); Brinase (INN) |
(P) unclassified |
D03164 |
Bromindione (USAN/INN) |
(P) unclassified |
D03208 |
Aliskiren (USAN/INN); Rasilez (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D03213 |
Apixaban (JAN/USAN/INN); Eliquis (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D03217 |
Avanafil (USAN/INN); Stendra (TN); Spedra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03237 |
Natural aluminum silicate (JP18); Aluminum silicate, natural (JAN); Adsorbin (TN) |
(P) unclassified |
D03253 |
Brecanavir (USAN) |
(P) unclassified |
D03259 |
Gemtuzumab ozogamicin (USAN); Gemtuzumab ozogamicin (genetical recombination) (JAN); Gemtuzumab (INN); Mylotarg (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03324 |
Nasaruplase (cell culture) (JAN); Prourokinase (plasminogen activator prolyse) |
(P) unclassified |
D03337 |
Reviparin sodium (JAN); Clivarine (TN) |
(P) unclassified |
D03341 |
Urokinase (JP18/USAN/INN); Abbokinase (TN) |
(P) unclassified |
D03352 |
Batroxobin (JAN/INN); Defibrase (TN) |
(P) unclassified |
D03353 |
Dalteparin sodium (JAN/USP/INN); Ardeparin sodium; Fragmin (TN) |
(P) unclassified |
D03359 |
Cangrelor (USAN/INN) |
(P) unclassified |
D03361 |
Cangrelor tetrasodium (USAN); Kengreal (TN) |
(P) unclassified |
D03385 |
Carbaspirin calcium (USAN); Carbasalate calcium (INN) |
(P) unclassified |
D03505 |
Cinacalcet hydrochloride (JAN/USAN); Sensipar (TN); Mimpara (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03536 |
Clentiazem maleate (JAN/USAN) |
(P) unclassified |
D03562 |
Clorazepate monopotassium (USAN) |
(P) unclassified |
D03631 |
Cyprazepam (USAN/INN) |
(P) unclassified |
D03644 |
Danaparoid sodium (JAN/USAN); Orgaran (TN) |
(P) unclassified |
D03655 |
Darodipine (USAN/INN) |
(P) unclassified |
D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03657 |
Dasantafil (USAN/INN) |
(P) unclassified |
D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03661 |
Dazmegrel (USAN/INN) |
(P) unclassified |
D03663 |
Dazoxiben hydrochloride (USAN) |
(P) unclassified |
D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
D03671 |
Deflazacort (USAN/INN); Emflaza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D03673 |
Deligoparin sodium (USAN/INN) |
(P) unclassified |
D03674 |
Enoxaparin sodium (JAN/USP/INN); Lovenox (TN) |
(P) unclassified |
D03692 |
Desirudin (USAN/INN); Iprivask (TN) |
(P) unclassified |
D03695 |
Desmoteplase (USAN/INN) |
(P) unclassified |
D03722 |
Efegatran sulfate (USAN) |
(P) unclassified |
D03728 |
Napsagatran (USAN) |
(P) unclassified |
D03737 |
Dextofisopam (USAN/INN) |
(P) unclassified |
D03798 |
Dicumarol (USAN); Dicoumarol (INN); Dicumarol (TN) |
(P) unclassified |
D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D03839 |
Droxinavir hydrochloride (USAN) |
(P) unclassified |
D03840 |
Palinavir (USAN/INN) |
(P) unclassified |
D03842 |
Telinavir (USAN/INN) |
(P) unclassified |
D03843 |
Tipranavir disodium (USAN) |
(P) unclassified |
D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) unclassified |
D03918 |
Drotrecogin alfa (activated) (USAN); Drotrecogin alfa; Xigris (TN) |
(P) unclassified |
D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D04029 |
Razaxaban hydrochloride (USAN) |
(P) unclassified |
D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D04183 |
Fidexaban (USAN/INN) |
(P) unclassified |
D04193 |
Flordipine (USAN/INN) |
(P) unclassified |
D04248 |
Fosazepam (USAN/INN) |
(P) unclassified |
D04260 |
Fostedil (USAN/INN) |
(P) unclassified |
D04276 |
Furegrelate sodium (USAN) |
(P) unclassified |
D04322 |
Gliamilide (USAN/INN) |
(P) unclassified |
D04354 |
Glyhexamide (USAN/INN); Subose (TN) |
(P) unclassified |
D04355 |
Glyoctamide (USAN/INN) |
(P) unclassified |
D04356 |
Glyparamide (USAN) |
(P) unclassified |
D04427 |
Heparin calcium (JP18); Nadroparin calcium (INN); Calciparin; Calciparine (TN) |
(P) unclassified |
D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D04650 |
Ketazolam (USAN/INN) |
(P) unclassified |
D04657 |
Lacidipine (USAN/INN); Motens (TN) |
(P) unclassified |
D04665 |
Lanoteplase (USAN/INN); Lanoteplase (genetical recombination) (JAN) |
(P) unclassified |
D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
D04721 |
Levotofisopam (USAN/INN) |
(P) unclassified |
D04733 |
Lidoflazine (USAN/INN); Angex (TN) |
(P) unclassified |
D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(CI,P) unclassified |
D04799 |
Heparinoid (JAN); Hirudoid (TN) |
(P) unclassified |
D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D04882 |
Medazepam hydrochloride (USAN); Nobrium (TN) |
(P) unclassified |
D04977 |
Parnaparin sodium (JP18); Lowhepa (TN) |
(P) unclassified |
D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) unclassified |
D05028 |
Midazolam maleate (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D05123 |
Nasaruplase beta (USAN/INN); Prolyse (TN) |
(P) unclassified |
D05181 |
Aspirin aluminum (JP18) |
(P) unclassified |
D05246 |
Olmesartan (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D05339 |
Paliperidone (JAN/USP/INN); Invega (TN) |
(P) unclassified |
D05340 |
Paliperidone palmitate (JAN/USAN); Xeplion (TN); Trevicta (TN); Invega sustenna (TN); Invega trinza (TN) |
(P) unclassified |
D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
D05410 |
Pamiteplase (INN); Pamiteplase (genetical recombination) (JAN); Solinase (TN) |
(P) unclassified |
D05412 |
Monteplase (INN); Monteplase (genetical recombination) (JAN); Cleactor (TN) |
(P) unclassified |
D05429 |
Aminophylline hydrate (JP18) |
(P) unclassified |
D05442 |
Perhexiline maleate (USAN) |
(P) unclassified |
D05457 |
Phenprocoumon (USAN/INN); Liquamar (TN) |
(P) unclassified |
D05462 |
Oxycodone hydrochloride hydrate (JP18) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D05502 |
Pirmagrel (USAN/INN); CGS 13080 |
(P) unclassified |
D05538 |
Mozenavir (INN) |
(P) unclassified |
D05597 |
Prasugrel hydrochloride (JAN/USAN); Effient (TN) |
(P) unclassified |
D05681 |
Quinine ascorbate (USAN); Quinine biascorbate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D05700 |
Ranolazine (USAN/INN); Ranexa (TN) |
(P) Transporter inhibition: ABCB1 |
D05701 |
Ranolazine hydrochloride (USAN) |
(P) Transporter inhibition: ABCB1 |
D05710 |
Reclazepam (USAN/INN) |
(P) unclassified |
D05721 |
Reteplase (USAN/INN); Retevase (TN) |
(P) unclassified |
D05727 |
Ridogrel (USAN/INN) |
(P) unclassified |
D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D05942 |
Sulazepam (USAN/INN) |
(P) unclassified |
D06060 |
Teludipine hydrochloride (USAN) |
(P) unclassified |
D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06070 |
Tenecteplase (USAN/INN); Tnkase (TN) |
(P) unclassified |
D06103 |
Theophylline (USP); Theophylline monohydrate; Accurbron (TN) |
(P) unclassified |
D06104 |
Theophylline sodium glycinate (USP); Asbron (TN) |
(P) unclassified |
D06142 |
Tifacogin (USAN/INN) |
(P) unclassified |
D06177 |
Tolbutamide sodium, sterile; Orinase diagnostic (TN) |
(P) unclassified |
D06186 |
Tolpyrramide (USAN/INN) |
(P) unclassified |
D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06213 |
Treprostinil (JAN/USAN/INN); Remodulin (TN) |
(P) unclassified |
D06231 |
Triflubazam (USAN/INN) |
(P) unclassified |
D06270 |
Urokinase alfa (USAN/INN); r-UK (TN) |
(P) unclassified |
D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06363 |
Ziconotide (USAN/INN); Prialt (TN) |
(P) unclassified |
D06390 |
Azithromycin (USP); Zmax (TN) |
(P) Transporter inhibition: ABCB1 |
D06398 |
Tinzaparin sodium (USAN); Innohep (TN) |
(P) unclassified |
D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06405 |
Nalfurafine hydrochloride (JAN/USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06410 |
Thrombomodulin alfa (USAN/INN); Thrombomodulin alfa (genetical recombination) (JAN) |
(P) unclassified |
D06412 |
Aliskiren fumarate (JAN/USAN); Aliskiren hemifumarate; Tekturna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06466 |
Freeze-dried BCG for intravesical use; Immunobladder (TN); Tice BCG (TN) |
(P) unclassified |
D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06571 |
Antithrombin III human (USP); Antithrombin III (INN); Kybernin (TN) |
(P) unclassified |
D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D06623 |
Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate; Zyprexa (TN) |
(P) unclassified |
D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
D06670 |
Maraviroc (JAN/INN); Selzentry (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D06879 |
Streptokinase (INN); Streptase (TN) |
(P) unclassified |
D06880 |
Lepirudin (INN); Refludan (TN) |
(P) unclassified |
D06888 |
Eptifibatide (INN); Integrilin (TN) |
(P) unclassified |
D07064 |
Acenocoumarol (INN); Acenocoumarin; Mini-sintrom (TN) |
(P) unclassified |
D07082 |
Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN); Dabigatran etexilate mesilate; Pradaxa (TN) |
(CI,P) Transporter inhibition: ABCB1 |
D07086 |
Rivaroxaban (JAN/USAN/INN); Xarelto (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D07113 |
Loperamide oxide (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D07117 |
Metahexamide (INN) |
(P) unclassified |
D07118 |
Glisoxepide (INN) |
(P) unclassified |
D07131 |
Ethyl biscoumacetate (INN) |
(P) unclassified |
D07135 |
Clorindione (INN); G-25766 |
(P) unclassified |
D07136 |
Diphenadione (INN) |
(P) unclassified |
D07137 |
Tioclomarol (INN) |
(P) unclassified |
D07138 |
Ditazole (INN) |
(P) unclassified |
D07139 |
Cloricromen (INN) |
(P) unclassified |
D07140 |
Picotamide (BAN); Plactidil (TN) |
(P) unclassified |
D07141 |
Indobufen (INN) |
(P) unclassified |
D07142 |
Triflusal (INN) |
(P) unclassified |
D07143 |
Melagatran (INN) |
(P) unclassified |
D07144 |
Dabigatran etexilate (USAN/INN); Pradaxa (TN) |
(P) Transporter inhibition: ABCB1 |
D07185 |
Fendiline (INN) |
(P) unclassified |
D07314 |
Pinazepam (INN); Domar (TN) |
(P) unclassified |
D07315 |
Camazepam (INN) |
(P) unclassified |
D07326 |
Loprazolam (INN); Dormonoct (TN) |
(P) unclassified |
D07327 |
Doxefazepam (INN) |
(P) unclassified |
D07328 |
Cinolazepam (INN); Gerodorm (TN) |
(P) unclassified |
D07421 |
Aloxiprin (INN); Superpyrin (TN) |
(P) unclassified |
D07422 |
Fibrinolysin (human) (INN); Fibrinolysin, human; Fibrogammin (TN) |
(P) unclassified |
D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07457 |
Anisindione (INN); Miradon (TN) |
(P) unclassified |
D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
D07474 |
Atorvastatin (INN); Lipitor (TN); Sortis (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D07486 |
Azithromycin (INN); Azasite (TN); Azithromycin (TN) |
(P) Transporter inhibition: ABCB1 |
D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07509 |
Benidipine (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07510 |
Adomiparin (USAN); Semuloparin (USAN); Heparin (BAN); Enoxaparin; Bemiparin; Parnaparin; Nadroparin; Heparin (TN) |
(P) unclassified |
D07520 |
Bepridil (INN); Bepadin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07545 |
Brovincamine (INN); Sarbromin (TN) |
(P) unclassified |
D07569 |
Candesartan cilexetil and anmlodipine besylate (JP18); Unisia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07579 |
Aspirin calcium salt; Notras (TN) |
(P) unclassified |
D07580 |
Aspirin DL-lysine (JAN); Aspirin lysine salt; Aspegic (TN) |
(P) unclassified |
D07581 |
Aspirin magnesium salt; Mobidin (TN) |
(P) unclassified |
D07582 |
Aspirin sodium; Sodium acetylsalicylate; Catalgine (TN) |
(P) unclassified |
D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
D07585 |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP induction: CYP3A4 |
D07662 |
Cetirizine (INN); Cetiderm (TN) |
(P) Transporter inhibition: ABCB1 |
D07704 |
Citalopram (USP/INN); Citadur (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D07705 |
Citalopram hydrochloride; Seropram (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D07714 |
Climazolam (INN); Climasol [veterinary] (TN) |
(P) unclassified |
D07729 |
Clopidogrel (USP/INN); Clopidogrel (TN); Plavix (TN) |
(P) unclassified |
D07736 |
Cloricromen hydrohloride; Proendotel (TN) |
(P) unclassified |
D07784 |
Delorazepam (INN); Dadumir (TN) |
(P) unclassified |
D07845 |
Diltiazem (INN); Surazem (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07866 |
Docetaxel (JAN/INN); Docetaxel (TN); Taxotere (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07886 |
Efonidipine (INN) |
(P) unclassified |
D07906 |
Ergotamine (INN) |
(CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D07943 |
Fendiline hydrochloride; Sensit (TN) |
(P) unclassified |
D07969 |
Fluindione (INN); Previsccan (TN) |
(P) unclassified |
D07971 |
Flunarizine (INN); Sibelium (TN) |
(P) unclassified |
D08004 |
Gabexate (INN) |
(P) unclassified |
D08009 |
Gallopamil (INN) |
(P) unclassified |
D08065 |
Iloprost tromethamine; Iloprost trometamol; Ventavis (TN) |
(P) unclassified |
D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08108 |
Lapatinib (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D08111 |
Lercanidipine (INN); Lercanil (TN) |
(P) unclassified |
D08144 |
Loperamide (INN); Diamide (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D08145 |
Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) |
(P) unclassified |
D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08195 |
Methadone (BAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
D08217 |
Mibefradil (INN) |
(P) unclassified |
D08240 |
Nafamostat (INN) |
(P) unclassified |
D08256 |
Nateplase (INN); Milyzer (TN); Tepase (TN) |
(P) unclassified |
D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08270 |
Nicardipine (INN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08283 |
Nordazepam (INN); Calmday (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08327 |
Ozagrel (INN); Cataclot (TN) |
(P) unclassified |
D08340 |
Perhexiline (INN) |
(P) unclassified |
D08354 |
Phenindione (INN); Hedulin (TN) |
(P) unclassified |
D08456 |
Quetiapine (INN); Norsic (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08460 |
Quinine (BAN); Kinder Quinina (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D08461 |
Quinine dihydrochloride; Quinine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 |
D08481 |
Rilmazafone (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08497 |
Rupatadine fumarate (JAN); Rinialer (TN); Rupafin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08508 |
Sarpogrelate (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08514 |
Sildenafil (INN); Aphrodil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08536 |
Suleparoid; Heparitin sulfate; Aremin (TN) |
(P) unclassified |
D08547 |
Sulodexide (INN); Vessel (TN) |
(P) unclassified |
D08594 |
Ticlopidine (INN); Ticlopidin-Puren (TN) |
(P) unclassified |
D08605 |
Tipranavir (INN); Aptivus (TN) |
(P) unclassified |
D08607 |
Tirofiban (INN); Agrastat (TN) |
(P) unclassified |
D08609 |
Tisokinase (JAN) |
(P) unclassified |
D08618 |
Topotecan (BAN); Hycamtin (TN) |
(P) Transporter inhibition: ABCB1 |
D08628 |
Treprostinil monosodium salt; Treprostinil sodium; Trepulmix (TN) |
(P) unclassified |
D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
D08668 |
Vardenafil (USAN/INN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) unclassified |
D08686 |
Ziconotide acetate; Prialt (TN) |
(P) unclassified |
D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08795 |
Human antithrombin III, freeze-dried concentrated; Neuart (TN) |
(P) unclassified |
D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08858 |
Antithrombin alfa (INN/USAN); Atryn (TN) |
(P) unclassified |
D08873 |
Betrixaban (USAN); Bevyxxa (TN) |
(P) unclassified |
D08892 |
Clevidipine (USAN/INN); Clevidipine butyrate; Cleviprex (TN) |
(P) unclassified |
D08898 |
Darinaparsin (JAN/USAN); Darvias (TN) |
(P) unclassified |
D08913 |
Eribaxaban (USAN) |
(P) unclassified |
D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D08953 |
Nilotinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) Transporter inhibition: ABCB1 |
D09187 |
Estradiol and levonorgestrel; Wellnara (TN); Climara pro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09206 |
Saruplase (INN); Prourokinase (enzyme activating) (human clone pUK4/pUK18), nonglycosylated |
(P) unclassified |
D09318 |
Indacaterol (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D09319 |
Indacaterol maleate (JAN/USAN); Arcapta neohaler (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09546 |
Edoxaban tosilate hydrate (JAN); Edoxaban tosylate monohydrate; Lixiana (TN); Savaysa (TN) |
(P) Transporter inhibition: ABCB1 |
D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) Transporter inhibition: ABCB1 |
D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(P) unclassified |
D09592 |
Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN); Invokana (TN) |
(P) Transporter inhibition: ABCB1 |
D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09621 |
Gisadenafil (USAN/INN) |
(P) unclassified |
D09622 |
Gisadenafil besylate (USAN) |
(P) unclassified |
D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09676 |
Tecarfarin (USAN/INN) |
(P) unclassified |
D09677 |
Tecarfarin sodium (USAN) |
(P) unclassified |
D09707 |
Dabigatran (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D09710 |
Edoxaban (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D09720 |
Rilpivirine (JAN/USAN/INN); Rekambys (TN) |
(P) unclassified |
D09724 |
Afatinib (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09733 |
Afatinib dimaleate (USAN); Afatinib maleate (JAN); Gilotrif (TN); Giotrif (TN) |
(P) Transporter inhibition: ABCB1 |
D09743 |
Telmisartan and amlodipine besilate (JP18); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09765 |
Vorapaxar (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09766 |
Vorapaxar sulfate (JAN/USAN); Zontivity (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09789 |
Kirenidipine hydrochloride (JAN) |
(P) unclassified |
D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
D09807 |
Difethiarol (JAN); Difethialone |
(P) unclassified |
D09814 |
Silteplase (INN); Silteplase (genetical recombination) (JAN) |
(P) unclassified |
D09817 |
Darexaban maleate (JAN); YM150 |
(P) unclassified |
D09823 |
Duteplase (INN); Duteplase (genetical recombination) (JAN) |
(P) unclassified |
D09847 |
Metildigoxin (INN); Medigoxin (BAN) |
(P) Transporter inhibition: ABCB1 |
D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP18); Pioglitazone and glimepiride; Duetact; Sonias (TN) |
(P) unclassified |
D09893 |
Eliglustat (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) Transporter inhibition: ABCB1 |
D09919 |
Lenvatinib (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) Transporter inhibition: ABCB1 |
D09923 |
Letaxaban (USAN/INN) |
(P) unclassified |
D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(P) unclassified |
D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09989 |
Vardenafil hydrochloride (USP) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09994 |
Selexipag (JAN/USAN/INN); Uptravi (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10027 |
Udenafil (USAN/INN) |
(P) unclassified |
D10065 |
Daclatasvir (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10081 |
Simeprevir (JAN/USAN) |
(P) Transporter inhibition: ABCB1 |
D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(CI,P) unclassified |
D10093 |
Asunaprevir (JAN/USAN); Sunvepra (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D10105 |
Daclatasvir dihydrochloride (USAN); Daclatasvir hydrochloride (JAN); Daklinza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10138 |
Regorafenib (USAN/INN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(CI,P) unclassified |
D10226 |
Sacubitril valsartan sodium hydrate (JAN); Sacubitril mixture with valsartan; Entresto (TN) |
(P) unclassified |
D10243 |
Irbesartan and amlodipine besilate (JP18); Aimix (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10264 |
Linagliptin and metformin hydrochloride; Jentaduet (TN) |
(P) Transporter inhibition: ABCB1 |
D10308 |
Baricitinib (JAN/USAN/INN); Olumiant (TN) |
(P) Transporter inhibition: ABCB1 |
D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10355 |
Aripiprazole cavoxil (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10364 |
Aripiprazole lauroxil (USAN); Aristada (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10366 |
Sofosbuvir (JAN/USAN/INN); Sovaldi (TN) |
(P) Transporter inhibition: ABCB1 |
D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
D10385 |
Ezetimibe and atorvastatin; Atozet (TN); Liptruzet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10396 |
Nintedanib esylate (USAN); Nintedanib ethanesulfonate (JAN); Ofev (TN) |
(P) Transporter inhibition: ABCB1 |
D10428 |
Tenofovir alafenamide (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D10430 |
Treprostinil diolamine (USAN); Orenitram (TN) |
(P) unclassified |
D10433 |
Vibegron (JAN/USAN/INN); Beova (TN); Gemtesa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
D10459 |
Empagliflozin (JAN/USAN/INN); Jardiance (TN) |
(P) Transporter inhibition: ABCB1 |
D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10469 |
Simeprevir sodium (JAN); Olysio (TN); Sovriad (TN) |
(P) Transporter inhibition: ABCB1 |
D10471 |
Idraparinux sodium (USAN) |
(P) unclassified |
D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10481 |
Nintedanib (USAN/INN); Ofev (TN) |
(P) Transporter inhibition: ABCB1 |
D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(P) Transporter inhibition: ABCB1 |
D10582 |
Dasabuvir, ombitasvir, paritaprevir and ritonavir; Viekira pak (TN) |
(P) CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10588 |
Empagliflozin and linagliptin; Glyxambi (TN) |
(P) Transporter inhibition: ABCB1 |
D10605 |
Tenofovir alafenamide fumarate (JAN/USAN); Vemlidy (TN) |
(P) Transporter inhibition: ABCB1 |
D10625 |
Elbasvir (JAN/USAN/INN); Erelsa (TN) |
(P) Transporter inhibition: ABCB1 |
D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10639 |
Grazoprevir (USAN); Grazoprevir hydrate (JAN); Grazyna (TN) |
(P) Transporter inhibition: ABCB1 |
D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(CI,P) unclassified |
D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(CI,P) unclassified |
D10684 |
Antithrombin gamma (INN); Antithrombin gamma (genetical recombination) (JAN); Acoalan (TN) |
(P) unclassified |
D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
D10707 |
Fostemsavir (USAN) |
(P) Transporter inhibition: ABCB1 |
D10708 |
Fostemsavir tromethamine (USAN); Fostemsavir trometamol; Rukobia (TN) |
(P) Transporter inhibition: ABCB1 |
D10709 |
Gilteritinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10711 |
Pemafibrate (JAN); Parmodia (TN) |
(P) unclassified |
D10733 |
Talazoparib tosylate (USAN); Talazoparib tosilate (JAN); Talzenna (TN) |
(P) unclassified |
D10734 |
Temsavir (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D10745 |
Ombitasvir, paritaprevir and ritonavir; Technivie (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10755 |
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide; Genvoya (TN) |
(P) unclassified |
D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(P) unclassified |
D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) same components |
D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10811 |
Fentanyl hydrochloride (JAN); Ionsys (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10823 |
Clopidogrel hydrochloride; Clopidogrel (TN) |
(P) unclassified |
D10824 |
Clopidogrel besilate; Clopidogrel besylate; Clopidogrel (TN) |
(P) unclassified |
D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(P) unclassified |
D10835 |
Emtricitabine and tenofovir alafenamide; Descovy (TN) |
(P) Transporter inhibition: ABCB1 |
D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(P) Transporter inhibition: ABCB1 |
D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10882 |
Daclatasvir, asunaprevir and beclabuvir; Ximency (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
D10888 |
Relugolix (JAN/USAN/INN); Orgovyx (TN) |
(P) Transporter inhibition: ABCB1 |
D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10915 |
Cannabidiol (USAN/INN); CBD; Epidiolex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11009 |
Indacaterol acetate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
D11014 |
Glecaprevir and pibrentasvir; Mavyret (TN) |
(P) Transporter inhibition: ABCB1 |
D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11029 |
Andexanet alfa (USAN/INN); Andexanet alfa (genetical recombination) (JAN); Andexxa (TN); Ondexxya (TN) |
(P) unclassified |
D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11095 |
Atorvastatin calcium propylene glycol solvate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
D11160 |
Caplacizumab (USAN/INN); Caplacizumab (genetical recombination) (JAN); Caplacizumab-yhdp; Cablivi (TN) |
(P) unclassified |
D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
D11280 |
Bivalirudin trifluoroacetate (USAN); Angiomax (TN) |
(P) unclassified |
D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(P) unclassified |
D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(P) unclassified |
D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11444 |
Tazemetostat (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) Transporter inhibition: ABCB1 |
D11520 |
Ezetimibe and rosuvastatin; Roszet (TN); Rosuzet (TN) |
(P) unclassified |
D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(P) unclassified |
D11565 |
Grazoprevir (USAN/INN); Grazoprevir anhydrous |
(P) Transporter inhibition: ABCB1 |
D11568 |
Edoxaban tosylate (USAN) |
(P) Transporter inhibition: ABCB1 |
D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
D11673 |
Berotralstat (USAN/INN) |
(P) CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11716 |
Odevixibat (USAN); Bylvay (TN) |
(P) Transporter inhibition: ABCB1 |
D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) unclassified |
D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
D12005 |
Treprostinil palmitil (USAN/INN) |
(P) unclassified |
D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
D12161 |
Lenacapavir (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
D12162 |
Lenacapavir sodium (JAN/USAN); Sunlenca (TN) |
(P) Transporter inhibition: ABCB1 |
D12269 |
Nirmatrelvir and ritonavir; Paxlovid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
D12446 |
Anpocogin (USAN) |
(P) unclassified |
D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
D12595 |
Aspirin trelamine (USAN) |
(P) unclassified |
D12596 |
Aspirin trelamine hydrochloride (USAN) |
(P) unclassified |
D12629 |
Treprostinil phosphate (USAN); Treprostinil biphosphate |
(P) unclassified |
D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
D12854 |
Nilotinib laurylsulfate (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |